KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Non-Current Assets: 2011-2025

Historic Other Non-Current Assets for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to $73.4 million.

  • Sarepta Therapeutics' Other Non-Current Assets rose 371.04% to $73.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.4 million, marking a year-over-year increase of 371.04%. This contributed to the annual value of $79.9 million for FY2024, which is 41.57% down from last year.
  • Latest data reveals that Sarepta Therapeutics reported Other Non-Current Assets of $73.4 million as of Q3 2025, which was down 11.73% from $83.1 million recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Other Non-Current Assets ranged from a high of $293.1 million in Q3 2022 and a low of $15.6 million during Q1 2024.
  • For the 3-year period, Sarepta Therapeutics' Other Non-Current Assets averaged around $98.5 million, with its median value being $83.1 million (2025).
  • As far as peak fluctuations go, Sarepta Therapeutics' Other Non-Current Assets crashed by 90.41% in 2024, and later skyrocketed by 417.05% in 2025.
  • Sarepta Therapeutics' Other Non-Current Assets (Quarterly) stood at $292.9 million in 2021, then slumped by 44.37% to $163.0 million in 2022, then declined by 16.08% to $136.8 million in 2023, then slumped by 41.57% to $79.9 million in 2024, then surged by 371.04% to $73.4 million in 2025.
  • Its Other Non-Current Assets was $73.4 million in Q3 2025, compared to $83.1 million in Q2 2025 and $80.6 million in Q1 2025.